Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England

C. Micallef, S. H. Aliyu, R. Santos, Nicholas Brown, D. Rosembert, D. A. Enoch*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)

Abstract

Background: Antifungal stewardship aims to promote the optimal use of antifungals through the careful selection of agents based on patient profile, target organism, toxicity, costs and the likelihood of emergence and spread of resistance. Methods: We report on an observational prospective 12 month study conducted by an antifungal stewardship team targeting the use of echinocandins (caspofungin and micafungin), voriconazole and liposomal amphotericin B in a tertiary referral hospital in the UK. Results: One-hundred-and-seventy-three patients were reviewed on 294 occasions. Clinical advice was given and implemented during review of 45 (88.2%) of micafungin prescriptions, 70 (78.7%) of those receiving voriconazole, 78 (62.4%) of those receiving liposomal amphotericin B and 3 (27.3%) of those receiving caspofungin. Except for voriconazole, nearly half of all treatments reviewed were stopped or changed. This study found that a crude cost saving of ~£180000 in antifungal drugs was generated compared with the previous year. Conclusions: Using a multidisciplinary team, antifungal stewardship can achieve significant improvements in patient management and it may reduce costs.

Original languageEnglish
Pages (from-to)1908-1911
Number of pages4
JournalJournal of Antimicrobial Chemotherapy
Volume70
Issue number6
DOIs
Publication statusPublished - 12 Nov 2014

Bibliographical note

Publisher Copyright:
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.

Keywords

  • Caspofungin
  • Liposomal amphotericin B
  • Micafungin
  • Voriconazole

Fingerprint

Dive into the research topics of 'Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England'. Together they form a unique fingerprint.

Cite this